Skip to main content

Research Repository

Advanced Search

Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ

Toss, Michael S.; Miligy, Islam M.; Gorringe, Kylie L.; Mittal, Karuna; Green, Andrew R.; Aneja, Ritu; Ellis, Ian O.; Rakha, Emad A.

Authors

Michael S. Toss

Islam M. Miligy

Kylie L. Gorringe

Karuna Mittal

Ritu Aneja

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology



Abstract

Aims: Cathepsin V (CTSV/CTSL2) is a lysosomal cystine proteinase and plays a role in extracellular matrix degradation. It is associated with poor prognosis in invasive breast cancer (IBC), but its role in breast ductal carcinoma in situ (DCIS) remains unclear. In this study, we aimed to evaluate the prognostic significance of CTSV in DCIS.
Methods: CTSV protein expression was immunohistochemically assessed in a well characterised and annotated cohort of DCIS comprising, pure DCIS (n=776) and DCIS coexisting with IBC (n=239). CTSV expression was analysed in tumour cells and surrounding stroma, including its association with clinicopathological parameters and outcome.
Results: In pure DCIS, high CTSV expression was observed in 29% of epithelial tumour cells and 20% of surrounding stroma. High expression in both components was associated with features of poor prognosis including higher nuclear grade, hormone receptor negativity and HER2 positivity. In addition, stromal CTSV expression was associated with larger DCIS size, comedo type necrosis and high proliferation index. DCIS associated with IBC showed higher CTSV expression than pure DCIS either within the epithelial tumour cells or surrounding stroma (p

Citation

Toss, M. S., Miligy, I. M., Gorringe, K. L., Mittal, K., Green, A. R., Aneja, R., …Rakha, E. A. (2020). Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ. Journal of Clinical Pathology, 73(2), 76-82. https://doi.org/10.1136/jclinpath-2019-205939

Journal Article Type Article
Acceptance Date Aug 10, 2019
Online Publication Date Aug 23, 2019
Publication Date 2020-02
Deposit Date Aug 12, 2019
Journal Journal of Clinical Pathology
Print ISSN 0021-9746
Electronic ISSN 1472-4146
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 73
Issue 2
Pages 76-82
DOI https://doi.org/10.1136/jclinpath-2019-205939
Keywords DCIS; proteolysis; CTSV; stroma; recurrence
Public URL https://nottingham-repository.worktribe.com/output/2419685
Publisher URL https://jcp.bmj.com/content/early/2019/08/22/jclinpath-2019-205939
Additional Information This article has been accepted for publication in Journal of Clinical Pathology following peer review, and the Version of Record can be accessed online at http://dx.doi.org/10.1136/jclinpath-2019-205939 © Authors (or their employer(s))